Japan Soft Gel Capsule Market Size, Share, By Type (Gelatine-Based, Non-Animal-Based), By Application (Pharmaceuticals, Nutraceuticals & Dietary Supplements), By End Use (Pharmaceutical and Nutraceutical Companies, Contract Manufacturing Organizations), Japan Soft Gel Capsule Market Insights, Industry Trends, Forecasts to 2035.
Industry: HealthcareJapan Soft Gel Capsules Market Insights Forecasts to 2035
- Japan Soft Gel Capsules Market Size 2024: USD 596.4 Mn
- Japan Soft Gel Capsules Market Size 2035: USD 1583.7 Mn
- Japan Soft Gel Capsules Market CAGR 2024: 9.28%
- Japan Soft Gel Capsules Market Segments: Type, Application, and End Use

Get more details on this report -
Soft Gel Capsules are an oral delivery system which provides precise dosage of liquid or semi-solid medications while enhancing their bioavailability and helping patients follow treatment plans. The Japanese market accepts these capsules because their pharmaceutical manufacturing standards ensure product quality and their design allows users to consume them without difficulty. Soft gel capsules main purposes include delivering pharmaceutical drugs and distributing nutraceuticals and dietary supplements. The medical community selects these products because they enable quick medicine absorption while maintaining precise dosage control for health supplements and functional ingredients. The aging population increasingly prefers easy-to-use medication solutions which will ensure these products remain popular.
The market development receives support from technological progress which has produced better encapsulation methods and more stable capsules and increased use of plant-based capsule materials. The market operations gain strength from the combination of strong local manufacturing capacity and growing dependence on contract manufacturing organizations. The future brings business potential through plant-based capsules and personalized solutions and preventive health products and high-end nutraceutical products that match Japanese consumer health trends.
Market Dynamics of the Japan Soft Gel Capsules Market:
The Japan Soft Gel Capsule Market Size experiences growth because people want dosage forms which they can take without difficulty. The market shows growth because people prefer accurate dosing solutions which provide better bioavailability and help patients follow their treatment plans.
High manufacturing costs and compliance expenses together with the need for gelatine raw materials and strict quality and regulatory requirements create market barriers which become more challenging when producing products at large quantities. The company creates challenges in establishing rapid capacity growth because of its supply chain instability and requirement for special encapsulation machinery.
The market provides strong growth potential because of two factors which include the rising use of non-animal-based capsules and the growing trend of businesses outsourcing their manufacturing work to contract manufacturers. The market will experience growth because of three factors which include better encapsulation technology and customized products and high-quality nutraceuticals.
Japan Soft Gel Capsules Market Report Coverage
| Report Coverage | Details |
|---|---|
| Base Year: | 2024 |
| Market Size in 2024: | USD 596.4 Million |
| Forecast Period: | 2024-2035 |
| Forecast Period CAGR 2024-2035 : | CAGR Of 9.28% |
| 2035 Value Projection: | USD 1583.7 Million |
| Historical Data for: | 2020-2023 |
| No. of Pages: | 240 |
| Tables, Charts & Figures: | 110 |
| Segments covered: | By Type, By Application |
| Companies covered:: | Fuji Capsule Co., Ltd. Catalent, Inc. Sirio Pharma Co., Ltd. Aenova Group Lonza Group / Capsugel Soft Gel Technologies, Inc. EuroCaps Ltd Captek Softgel International Procaps Group SA And Other Key Players |
| Pitfalls & Challenges: | COVID-19 Empact, Challenge, Future, Growth, & Analysis |
Get more details on this report -
Market Segmentation
The Japan soft gel capsules market share is classified into type, application, and end use.
By Type:
The Japan Soft Gel Capsule Market Size is divided by type into gelatine-based and non-animal-based. Among these, the gelatine-based segment dominated the share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. The segment maintains its dominance because of the extensive acceptance of pharmaceutical products together with its ability to deliver better encapsulation results and affordable pricing and existing production facilities and its ability to produce larger quantities and its ability to work effectively with various active pharmaceutical and nutraceutical components.
By Application:
The Japan Soft Gel Capsule Market Size is divided by application into pharmaceuticals and nutraceuticals & dietary supplements. Among these, the pharmaceuticals segment dominated the share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. The market maintains its dominance because of two main factors which include the increasing need for prescription medications and the growing popularity of soft gel products that enhance bioavailability and provide users with easy swallowing and accurate dosing while their use increases for both chronic health conditions and therapeutic medical procedures.
By End Use:
The Japan soft gel capsule market is divided by end use into pharmaceutical and nutraceutical companies and contract manufacturing organizations. Among these, the pharmaceutical and nutraceutical companies segment dominated the share in 2024 and is anticipated to grow at a remarkable CAGR during the forecast period. The segment maintains its leading position because in-house production capabilities enable businesses to control their formulation process and their brand portfolio strength together with regulatory compliance requirements and market demand for customized soft gel dosage forms.
Competitive Analysis:
The report offers the appropriate analysis of the key organisations/companies involved within the Japan soft gel capsules market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
Top Key Companies in Japan Soft Gel Capsules Market:
- Fuji Capsule Co., Ltd.
- Catalent, Inc.
- Sirio Pharma Co., Ltd.
- Aenova Group
- Lonza Group / Capsugel
- Soft Gel Technologies, Inc.
- EuroCaps Ltd
- Captek Softgel International
- Procaps Group SA
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Market Segment
This study forecasts revenue at the Japan, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the Japan soft gel capsules market based on the below-mentioned segments:
Japan Soft Gel Capsule Market, By Type
- Gelatine-Based
- Non-Animal-Based
Japan Soft Gel Capsule Market, By Application
- Pharmaceuticals
- Nutraceuticals & Dietary Supplements
Japan Soft Gel Capsule Market, By End Use
- Pharmaceutical and Nutraceutical Companies
- Contract Manufacturing Organizations
Frequently Asked Questions (FAQ)
-
What is the Japan soft gel capsules market size?Japan soft gel capsules market is expected to grow from USD 596.4 million in 2024 to USD 1,583.7 million by 2035, growing at a CAGR of 9.28% during the forecast period 2025-2035
-
What are the key growth drivers of the Japan soft gel capsules market?Market growth is driven by rising demand for easy-to-consume dosage forms, increasing pharmaceutical and nutraceutical production, preference for accurate dosing and improved bioavailability, and growing use of soft gel capsules among Japan’s aging and health-conscious population
-
What factors restrain the Japan soft gel capsules market?Market restraints include high manufacturing and compliance costs, dependence on gelatine raw materials, strict quality and regulatory requirements, supply chain volatility, and the need for specialized encapsulation equipment for large-scale production.
-
How is the Japan soft gel capsules market segmented?The market is segmented by type, application, and end use.
-
Who are the key players in the Japan soft gel capsules market?Key companies include Fuji Capsule Co., Ltd., Catalent, Inc., Sirio Pharma Co., Ltd., Aenova Group, Lonza Group / Capsugel, Soft Gel Technologies, Inc., EuroCaps Ltd, Captek Softgel International, and Procaps Group SA.
-
Who are the target audiences for this market report?The report targets market players, investors, end-users, government authorities, consulting and research firms, venture capitalists, and value-added resellers (VARs).
Need help to buy this report?